Home » Newsletters » BioWorld Science

BioWorld Science

June 22, 2010

View Archived Issues

Memantine reduces "off" time in Parkinson's disease

PYM-50028 can be delivered to patients with PD at preclinically efficacious doses

Proximagen Neuroscience claims new SSAO inhibitors

New JAK3 kinase inhibitors identified by Roche

Novartis claims new chemokine CXCR2 receptor antagonists

Astellas submits MAA for mirabegron in Japan

Taxus Element paclitaxel-eluting stent system launched in Europe

Roche amends trial protocols for taspoglutide phase III program

Phase I/II trial of new proapoptotic agent APR-246 advances

PX-478 shows antitumor activity in phase I trial in advanced solid tumors

177Lu-J591 shows safety and preliminary efficacy in metastatic CRPC

ALD-518 improves rheumatoid arthritis symptoms in phase II trial

FDA recommends approval of emergency contraceptive ulipristal

Bionomics completes phase I trial of BNC-210 for anxiety

Mitsubishi Tanabe's Remicade approved for ulcerative colitis in Japan

FDA committee recommends additional clinical testing to support flibanserin NDA

Valeant and Biovail agree to merge

Hematide shows promise to treat anemia in phase III trials in CRF

BL-1020 improves schizophrenia symptoms in phase IIb trial

Amplyx Pharmaceuticals presents novel carbapenems

Zydus receives permission for phase I trial of ZYOG-1 in India

Lodotra now available in 13 European countries for RA

Sosei to acquire Activus Pharma

FDA advises on phase III palifosfamide trial in metastatic soft tissue sarcoma

Exelixis regains rights to XL-184

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...